Data from 2023 Sample Registration Survey shows India’s IMR has been declining faster than global rate. Delhi, Karnataka, Himachal lead in gains, but regional gaps persist.
Though India has built a robust domestic biosimilar market, its international presence and the ability to lower prices as compared to small molecule generics remain limited.
In a written reply to a Parliament query, health ministry cited heavy patient load as the reason, adding that critical & emergency surgeries are being prioritised & conducted without delay.
BITS Pilani's start-up accelerator Conquest supports a new generation of founders through a zero-cost, zero-equity model, helping reimagine healthcare.
The South Korean company aims for a 'synergy between Samsung’s advanced technology & Xealth’s digital health platform,' linking care providers & patients.
The scheme offers free health coverage of up to Rs 5 lakh per family annually for economically weaker groups. So far, 66 hospitals in Delhi have joined the programme.
With bad loans shrinking & capital buffers stronger, urban co-op banks’ new umbrella body NUCFDC is now prioritising rollout of digital transformation.
If deal goes through, Greece will be 2nd foreign country to procure vehicle. Morocco was first; TATA Group has set up manufacturing unit there with minimum 30 percent indigenous content.
Many of you might think I got something so wrong in National Interest pieces written this year. I might disagree! But some deserve a Mea Culpa. I’d deal with the most recent this week.
COMMENTS